The Media Bottleneck: How Just – Evotec Biologics is Rethinking Biomanufacturing Logistics
In the high-stakes world of biopharmaceutical manufacturing, the focus is often placed on the final molecule—the complex protein therapy that...
biologics
Samsung Biologics Fortifies Global CDMO Dominance with $262 Million European Contract and Strategic Expansion
In a move that underscores its deepening entrenchment in the global biopharmaceutical supply chain, Samsung Biologics has announced a significant...
Strategic Synergy: Transcenta Therapeutics and WuXi Biologics Forge New Path in Bioprocessing Efficiency
In a significant move that underscores the ongoing evolution of biopharmaceutical manufacturing, Transcenta Therapeutics has announced a strategic licensing agreement...
Samsung Biologics Targets Global Dominance with $1.8 Billion Acquisition of PolyPeptide Group
In a strategic maneuver that signals a seismic shift in the Contract Development and Manufacturing Organization (CDMO) landscape, Samsung Biologics...
The Microbial Renaissance: NorthX Biologics and enGenes Biotech Forge New Path for E. coli-Based Protein Production
In a move set to redefine the economics and efficiency of biopharmaceutical manufacturing, Swedish contract development and manufacturing organization (CDMO)...
